Pregled bibliografske jedinice broj: 1281176
MASS SPECTROMETRY IMAGING FOR NEPHROTOXICITY EVALUATION OF DIFFERENT DOXORUBICIN FORMULATIONS
MASS SPECTROMETRY IMAGING FOR NEPHROTOXICITY EVALUATION OF DIFFERENT DOXORUBICIN FORMULATIONS // Recent achievements in nanotechnology – 10th anniversary of BNT Center University of Bialystok
Białystok, Poljska, 2023. str. 30-30 (predavanje, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 1281176 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
MASS SPECTROMETRY IMAGING FOR NEPHROTOXICITY EVALUATION OF DIFFERENT DOXORUBICIN FORMULATIONS
Autori
Kalčec, Nikolina ; Debeljak, Željko ; Drinković, Nikša ; Micek, Vedran ; Gorup, Dunja ; Ćurlin, Marija ; Mandić, Dario ; Bandjak, Ana ; Mimica, Suzana ; Günday-Türeli, Nazende ; Türeli, Emre ; Vinković Vrček, Ivana
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Skup
Recent achievements in nanotechnology – 10th anniversary of BNT Center University of Bialystok
Mjesto i datum
Białystok, Poljska, 28.05.2023. - 01.06.2023
Vrsta sudjelovanja
Predavanje
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
Doxorubicin ; Mass spectrometry ; Nanoformulations
Sažetak
The clinical application of the cytotoxic drug, doxorubicin (DOX), is limited by its toxicity to non-cancerous tissues which is likely to induce inflammatory changes in kidney tissues.1 Nanoformulations as novel drug delivery systems may favor site-specific drug accumulation and consequently reduce the harmful effects of DOX on non-targeted tissues.2 This study employed mass spectrometry imaging (MSI) to investigate the effects of different DOX formulations on non-targeted kidney tissues. The biochemical changes in kidney cryosections of Wistar rats treated intraperitoneally during 28 days (once per week) wth liposomal (LPS) and poly(lactic-co-glycolic acid) (PLGA)-based nanoformulations were compared to those induced by the conventional (CNV) formulation. The results showed that there was a significant overlap between different treatments, as demonstrated by principal component analysis (PCA) and Volcano plots of the average mass spectra. However, nanoformulation-specific fingerprint consisting of 59 m/z values was identified for the LPS and PLGA treatments, while histochemical fingerprint of 22 significant m/z values was found for the CNV formulation. The identified m/z values were associated with processes such as apoptosis, cell migration, and proliferation, and were confirmed by a metabolome database search. Further analysis showed that the effects of CNV and PLGA formulations were tissue-nonselective with greater histochemical alterations, while LPS caused the least significant changes in m/z values and showed more specific distribution in the kidney cortex substructures. The study demonstrated the potential of MSI in effectively differentiating the effects of DOX formulations on non-targeted tissues, highlighting its importance in drug development.3
Izvorni jezik
Engleski
POVEZANOST RADA
Projekti:
HRZZ-PZS-2019-02-4323 - Siguran pristup za razvoj nano-sustava za ciljanu isporuku lijekova u mozak (SENDER) (Vinković Vrček, Ivana, HRZZ ) ( CroRIS)
Ustanove:
Institut za medicinska istraživanja i medicinu rada, Zagreb,
Medicinski fakultet, Zagreb,
Klinički bolnički centar Osijek,
Medicinski fakultet, Osijek,
Sveučilište J. J. Strossmayera u Osijeku,
Hrvatsko katoličko sveučilište, Zagreb
Profili:
Nikša Drinković
(autor)
Dario Mandić
(autor)
Marija Ćurlin
(autor)
Suzana Mimica Matanović
(autor)
Željko Debeljak
(autor)
Nikolina Kalčec
(autor)
Ivana Vinković Vrček
(autor)
Dunja Gorup
(autor)